ACQUISITION OF INTRAVITREAL BIOLOGICAL MEDICINES FOR THE TREATMENT OF OCULAR DISEASES IN ORDER TO CONTINUE THE CONTRACT FOR THE OUTPATIENT SURGERY SERVICE.